Chronic inflammation underlies an array of chronic, non-communicable diseases, including various cardiovascular and metabolic diseases and cancer. Recent studies have also shown that the mechanisms involved in regulating immunity and metabolism are intricately linked. The term immunometabolism refers to that linkage. In this review, we will discuss immune cell-mediated regulation of metabolic homeostasis and pathology in major metabolic tissues. A particular focus is on macrophages, which play diverse roles in the inflammatory processes induced in noncommunicable diseases.
prolonged condition in which inflammation, tissue injury and attempts at repair coexist 1) . Although chronic inflammation may follow acute inflammation, in the most common NCDs of today, it likely begins insidiously as a low-grade, smoldering response with no manifestation of the cardinal signs of inflammation.
The innate immune system serves as the body's immediate first line of defense. The cells of the innate immune system recognize and respond to pathogens, but they do not confer long-lasting immunity to specific antigens. By contrast, the adaptive immune system creates immunological memory after an initial response to a specific . Kupffer cells thus appear to promote insulin resistance by activating inflammatory pathways within hepatocytes.
Macrophage mediated control of liver function
During the progression of T2D, insulin resistance increases 
Macrophages in skeletal muscle development and function
In addition to being a motor organ, skeletal muscle is a primary site of glucose uptake and accounts for approximately 80% of insulin-stimulated glucose disposal in humans 13) . Skeletal muscle contains a small resident macrophage population under physiological conditions (~200 cells/mg of muscle) 14) , but obesity in both mice and humans is reportedly associated with increases in muscle inflammatory gene expression, which is accompanied by macrophage infiltration 15, 16) . These macrophages are largely localized in small intermuscular adipose depots that arise within skeletal muscle in obese individuals 15) .
On the other hand, other reports show no obesity-related increase in skeletal muscle macrophage number 17, 18) , and the origin of the increased mononuclear cells seen in some obese subjects has not yet been determined. The role of macrophages in the mechanism underlying insulin resistance also remains unclear, though it is possible that inflammatory factors released from the intramuscular macrophages exert paracrine effects that cause local insulin resistance, as is seen in the liver.
Skeletal muscle has a remarkable ability to repair itself after injury. This regeneration is a highly orchestrated process involving the concerted activation of a variety of cellular and molecular responses. Macrophages are essential for skeletal muscle regeneration and remodeling 19, 20) . In a freeze-injury model, for instance, depletion of circulating monocytes using clodronate liposomes not only attenuates the inflammatory response, it also impedes repair processes, prolonging the clearance of necrotic myofibers and increasing muscle fat accumulation 21) .
Previous studies also showed that macrophages stimulate myogenic progenitor cell growth through both secretion of soluble mitogenic factors and the establishment of direct anti-apoptotic cell-cell contacts [22] [23] [24] .
Following a muscle injury, a phenotype transition among macrophages is reportedly essential for the muscle repair process 14) . For example, notexin-induced muscle injury leads to rapid recruitment from blood of inflammatory 25) .
Macrophages in type 2 diabetes
Insulin resistance and β cell dysfunction are two key pathological mechanisms contributing to T2D. The observation that proinflammatory signaling pathways can inhibit insulin signaling 26) provides a link between inflammation and insulin resistance. Recent studies have
shown that inflammation is also involved in the development of β cell dysfunction. In T2D subjects, for example, pancreatic islets exhibit histological changes characteristic of inflammation, including amyloid deposition 27) , immune cell
, cell death and fibrosis 29) . In addition, sections of pancreas from patients with T2D, C57BL/6 mice fed a highfat diet, db/db mice and GK rats all show elevated numbers of macrophages within islets 28) . High intake of glucose or palmitate reportedly induces secretion of chemokines from islets, which promotes monocyte migration, suggesting that the T2D islet milieu promotes macrophage infiltration. Palmitate is the most abundant saturated FFA in blood, and the deleterious effects of palmitate on β cells, collectively termed "lipotoxicity," are well documented 31) . In vitro studies have shown that β cell lipotoxicity is directly induced by palmitate, at least in part via pathways primarily involving endoplasmic reticulum stress and reactive oxygen species.
After developing a method to increase serum free palmitate levels through infusion of emulsified ethyl palmitate, we 
Thus the chemokines from β cells and cytokines from M1
macrophages form a vicious cycle that exacerbates islet inflammation (Fig. 2) . M1 macrophage accumulation within islets appears to similarly contribute to β cell dysfunction in db/db and KKAy mice, two models of T2D. These results clearly demonstrate that activation of inflammatory processes within islets leads to β cell dysfunction.
Appetite control by macrophages
In addition to peripheral metabolic tissues such as adipose tissue and liver, obesity also reportedly activates inflammatory signaling within the central nervous system (CNS), including in the hypothalamus 32) . The hypothalamus is the control center for regulating whole-body energy homeostasis, and inhibiting hypothalamic inflammatory mediators such as c-Jun N-terminal kinase (JNK) and NF-κB diminishes insulin resistance in obese animals 33) .
Moreover, inhibition of inflammatory signaling specifically within Agouti-related peptide (AgRP) neurons, which stimulate feeding behavior, protects against obesity and glucose intolerance.
Microglia are the resident macrophages in the CNS. They arise from progenitors in the yolk sac and are maintained by self-renewal 34) . During development, they colocalize with dying neurons, suggesting they are involved in regulating neuronal number and development. Microglia share many functions with peripheral tissue macrophages, including an ability to carry out phagocytosis and release various High-fat diet-induced obesity leads to chronic lowgrade hypothalamic inflammation that involves activation of both microglia and astrocytes [35] [36] [37] . In rats, hypothalamic inflammation that includes elevated expression of IL-6 and TNF-α mRNA is evident within 1 to 3 days after starting a high-fat diet, prior to substantial weight gain. This inflammatory process eventually leads to neuronal injury. Indeed, markers suggestive of neuronal injury (e.g., Hsp72) are detected in the hypothalamic arcuate nucleus and adjacent median eminence within the first week after initiating a high-fat diet, and are associated with the development of reactive gliosis reflected by recruitment of microglia and astrocytes 36) . Interestingly, pro-opiomelanocortin (POMC)
neurons are much more vulnerable to a high-fat diet than other types of neurons in the arcuate nucleus 37) . As . In addition, NF-κB, a major regulator of inflammatory responses, mediates leptin resistance in the hypothalamus 33) . It thus appears that a high-fat diet and obesity lead to activation of inflammatory signaling within the hypothalamus, which can modulate hypothalamic function, altering the regulation of feeding behavior and systemic metabolism.
Long-chain saturated fatty acids, but not unsaturated fatty acids, trigger hypothalamic inflammatory responses through activation of TLR4 on microglia, leading to leptin resistance 36) . Inhibition of TLR4 signaling not only suppresses inflammatory cytokine expression within the hypothalamus, it suppresses weight gain. Leptin also reportedly activates microglia and increases IL-6 production through the leptin receptor, PI3K and NF-κB pathways 38) , which suggests microglia are able to sense systemic adiposity and in turn mediate inflammatory responses ( . The ability of the systemic metabolic status to affect cellular metabolism adds further complexity to the immunometabolic interplay at the cellular level. It is therefore anticipated that a better understanding of the immunometabolic mechanisms underlying NCDs will provide a variety of novel therapeutic targets.
